1.A comparative study on Pulmonary function test results between the Morris and the Filpino standards.
Diaz Dina V ; Santos Eula Martha E
Philippine Journal of Internal Medicine 2013;51(1):56-
Pulmonary Function tests are widely used in clinical practice in the assessment of a variety of patients. the values obtained in this test are obtained using the standard formula made by Morris et al based on the age and height of Caucasian population.
in this study, a comparison was made of the PFT results of 358 patients using both the Morris Standard formula and those made by Roa et al based on a filipino population, using the statistical program MICROSTAT. results revealed a statistically significant difference in practically all variables, except for the FEV% and the FVC in males, this means therefore that the filipino standard developed by Roa et al should be used since the final patient classification significantly changes.
Human ; Male ; Female ; Middle Aged ; Comparative ; Study ; Pulmonary ; Function
2.Comparative Studies on Various Editions of \lq\lq\it{Kokon Hoi}\rq\rq
Kampo Medicine 2008;59(4):609-615
The “Kokon Hoi” was compiled by Koga Tsugen and was the most widely used formulary in the Edo era. Here are the results of this author's examination of various “Kokon Hoi” editions.1) Koga Tsugen received the source book of “Kokon Hoi” from the publisher Umemura, and compiled “Sanpo Kokon Hoi”.2) The original edition of “Kokon Hoi” was published by Umemura in around1692. This edition was a lengthwise book and contained 1263 prescriptions, which is the fewest of all the editions examined here.3) Umemura published an expanded edition of the original “Kokon Hoi” around1696. This was an oblong book, and included almost all of the prescriptions of the original “Kokon Hoi” with an additional 273 prescriptions.4) At the request of Umemura, Koga Tsugen published “Sanpo Kokon Hoi” with an additional 348 prescriptions in 1733, and subsequently, “Jutei Kokon Hoi” with an additional 43 prescriptions in 1747. “Jutei Kokon Hoi” was then reprinted in the years 1780, 1808 and 1862.
Books
;
Editions
;
Comparative Study
;
historical period
;
seconds
3.Initial Experiences with Laparoscopy-assisted and Total Laparoscopy for Anatomical Liver Resection: A Preliminary Study.
Seog Ki MIN ; Ho Seong HAN ; Sun Whe KIM ; Yong Hyun PARK ; Hyeon Kook LEE ; Joo Ho LEE
Journal of Korean Medical Science 2006;21(1):69-74
Although laparoscopic surgery has become more popular, its technical difficulties have limited the applications of this technique to liver surgery. We report here on our experience with liver resection with using the laparoscopy-assisted (Lap-Assist) and total laparoscopic (Total-Lap) methods. From April 2001 to June 2003, a total of 20 laparoscopic anatomical resections of the liver were retrospectively reviewed. These were comprised of 10 cases in which the Lap-Assist method was used (these were performed during the early study period), and 10 cases in which the Total-Lap was used (these were done in the later study period). In the Lap-Assist group, the following resections were performed: 7 cases of left lateral sectionectomy, a case of left hemihepatectomy, a case of right hemihepatectomy and a case of open conversion. In the Total-Lap group, 6 cases of left hemihepatectomy and 4 cases of left lateral sectionectomy were performed. The sizes of the incisions were 8.7 cm and 4.6 cm, respectively, (p=0.000). There were no differences in the operation times, the transfusion amounts, the starting days of the patients' diets, the complication rates or the durations of the hospital stay between the two groups. Both the laparoscopy-assisted method and the total laparoscopic method are feasible to use for performing anatomical liver resection.
Adult
;
Aged
;
Carcinoma, Hepatocellular/surgery
;
Cholelithiasis/surgery
;
Comparative Study
;
Female
;
Follow-Up Studies
;
Hepatectomy/*methods
;
Humans
;
Laparoscopy/*methods
;
Length of Stay
;
Liver/pathology/*surgery
;
Liver Neoplasms/surgery
;
Male
;
Middle Aged
;
Treatment Outcome
4.Mesenchymal Hamartomas of the Liver: Comparison of Clinicopathologic Features between Cystic and Solid Forms.
Hee Jin CHANG ; So Young JIN ; Chanil PARK ; Young Nyun PARK ; Ja June JANG ; Cheol Keun PARK ; Yeon Lim SUH ; Eunsil YU ; Dae Young KANG ; Han Ik BAE
Journal of Korean Medical Science 2006;21(1):63-68
Mesenchymal hamartoma (MH) of the liver is an uncommon benign lesion related to ductal plate malformation. It is usually cystic and mainly composed of myxoid mesenchymal tissue with tortuous or cystic bile ducts. In order to characterize the clinicopathological features of MH, the Korean Gastrointestinal Pathology Study Group collected a total of 17 MH cases diagnosed in 7 hospitals from 1992 to 2002 and compared the clinicopathologic findings of cystic MH with those of solid variant. Among the 17 cases, 7 (41%) were solid. The solid form showed a higher serum level of alpha-fetoprotein (AFP), the smaller bile ducts, and more frequent proliferation of vessels. Serum AFP level was related to the amount of hepatocytes. Two of seven solid cases harbored a larger amount of evenly distributed hepatocytes and proliferation of small duct with focal hepatocyte-bile duct transition. These histologic findings are similar to those of mixed hamartoma. Therefore, the mixed hamartoma and the MH of both solid and cystic types could be the variants of one disease spectrum. And hepatocytes within MH might be rather a genuine tumor component than entrapped into the tumor. In conclusion, MH can show various clinicopathological features and recognition of these features will facilitate accurate diagnosis of MH.
Adult
;
Aged
;
Child
;
Child, Preschool
;
Comparative Study
;
Cysts/pathology
;
Female
;
Hamartoma/*pathology
;
Humans
;
Infant
;
Liver/pathology
;
Liver Diseases/*pathology
;
Male
5.Comparison of the Efficacy of Oral Capecitabine versus Bolus 5-FU in Preoperative Radiotherapy of Locally Advanced Rectal Cancer.
Jae Sung KIM ; Jun Sang KIM ; Moon June CHO ; Wan Hee YOON ; Kye Sang SONG
Journal of Korean Medical Science 2006;21(1):52-57
The effects of treatment with oral capecitabine vs. bolus 5-FU, administered concurrently with preoperative radiotherapy, were compared in the treatment of locally advanced rectal cancer (LARC). One hundred and twenty-seven patients with LARC received concurrent preoperative chemoradiation using two cycles bolus 5-FU (500 mg/m2/day) plus leucovorin (LV, 20 mg/m2/day) (Group I). Another LARC group received concurrent chemoradiation using two cycles 1,650 mg/m2/day of oral capecitabine and 20 mg/m2/day of LV (Group II, 97 patients). Radiation was delivered to the primary tumor at 50.4 Gy in both groups. Definitive surgery was performed 6 weeks after the completion of chemoradiation. A pathologic complete remission was achieved in 11.4% of patients in Group I and in 22.2% of patients in Group II (p= 0.042). The down-staging rates of the primary tumor and lymph nodes were 39.0/ 68.7% in Group I and 61.1/87.5% in Group II (p=0.002/0.005). Sphincter-preserving surgery was possible in 42.1% of patients in Group I and 66.7% of those in Group II (p=0.021). Grade 3 or 4 leucopenia, diarrhea, and radiation dermatitis were statistically more prevalent in Group I than in Group II, while the opposite was true for grade 3 hand-foot syndrome. Preoperative chemoradiation using oral capecitabine was better tolerated than bolus 5-FU and was more effective in the promotion of both down-staging and sphincter preservation in patients with LARC.
Administration, Oral
;
Adult
;
Aged
;
Antimetabolites, Antineoplastic/administration & dosage/adverse effects/therapeutic use
;
Combined Modality Therapy
;
Comparative Study
;
Deoxycytidine/administration & dosage/adverse effects/*analogs & derivatives/therapeutic use
;
Diarrhea/chemically induced
;
Drug Administration Schedule
;
Fatigue/chemically induced
;
Female
;
Fluorouracil/administration & dosage/adverse effects/*therapeutic use
;
Humans
;
Leukopenia/chemically induced
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Postoperative Complications/therapy
;
Rectal Neoplasms/*drug therapy/radiotherapy/surgery
;
Retrospective Studies
;
Treatment Outcome
6.The Hematologic Response to Anti-apoptotic Cytokine Therapy: Results of Pentoxifylline, Ciprofloxacin, and Dexamethasone Treatment for Patients with Myelodysplastic Syndrome.
Min Kyoung KIM ; Jae Lyun LEE ; Hee Soon CHO ; Sung Hwa BAE ; Hun Mo RYOO ; Kyung Hee LEE ; Myung Soo HYUN
Journal of Korean Medical Science 2006;21(1):40-45
TNF-alpha mediated apoptosis of the hematopoietic cells has been thought to contribute to the ineffective hematopoiesis observed in myelodysplastic syndrome (MDS). The combination of pentoxifylline (P) and ciprofloxacin (C) has been shown to reduce the serum levels of TNF-alpha, and an earlier trial of P and C with dexamethasone (D) provided good palliation for patients with MDS. The purpose of this study is to assess the hematologic response to PCD therapy for patients suffering with MDS. 21 of 25 patients who completed at least of 12 weeks of treatment were evaluable for the treatment efficacy. At baseline, the patient's median age was 60 yr (range: 18-75 yr). The diagnoses according to WHO classification included: RA (n=5), RCMD (n=10), RARS (n=1), RCMD/RS (n=1), RAEB (3), and CMML (n=1). 11 patients (52%) had at least single lineage response. 3 patients (11%) showed improvement of triple lineage cytopenia. There were no differences in the response rates between the FAB subtypes. The median time to response was 4 weeks (range: 2-12 weeks), and it is interesting that 9 of 11 patients who had a response remained without relapse for a median of 177 days (range: 78-634 days). These preliminary results indicate that anti-cytokine therapy with PCD is an effective and well tolerated palliative treatment for patients with MDS.
Adolescent
;
Adult
;
Aged
;
Anti-Infective Agents/adverse effects/therapeutic use
;
Anti-Inflammatory Agents/adverse effects/therapeutic use
;
Apoptosis/*drug effects
;
Ciprofloxacin/adverse effects/therapeutic use
;
Comparative Study
;
Dexamethasone/adverse effects/therapeutic use
;
Drug Therapy, Combination
;
Erythrocyte Count
;
Female
;
Hematologic Agents/adverse effects/therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Myelodysplastic Syndromes/*blood/drug therapy
;
Nausea/chemically induced
;
Pentoxifylline/adverse effects/therapeutic use
;
Platelet Count
;
Time Factors
;
Treatment Outcome
;
Tumor Necrosis Factor-alpha/*metabolism
7.Aprotinin Attenuates the Elevation of Pulmonary Vascular Resistance After Cardiopulmonary Bypass.
Journal of Korean Medical Science 2006;21(1):25-29
Pulmonary vascular resistance (PVR) is generally believed to be elevated after cardiopulmonary bypass (CPB) due to whole body inflammation. Aprotinin has an antiinflammatory action, and it was hypothesized that aprotinin would attenuate the PVR increase induced by CPB. Ten mongrel dogs were placed under moderately hypothermic CPB for 2 hr. The experimental animals were divided into a control group (n=5, group I) and an aprotinin group (n=5, group II). In group II, aprotinin was administered during pre-bypass (50,000 KIU/kg) and post-bypass (10,000 KIU/kg) periods. Additional aprotinin (50,000 KIU/kg) was mixed in CPB priming solution. PVRs at pre-bypass and post-bypass 0, 1, 2, 3 hr were calculated, and lung tissue was obtained after the experiment. Post-bypass PVRs were significantly higher than prebypass levels in all animals (n=10, p<0.001). PVR elevation in group II was less than in group I at 3 hr post-bypass (p=0.0047). Water content of the lung was lower in group II (74+/-9.4%) compared to that of group I (83+/-9.5%), but the difference did not reach significance (p=0.076). Pathological examination showed a near normal lung structure in group II, whereas various inflammatory reactions were observed in group I. We concluded that aprotinin may attenuate CPB-induced PVR elevation through its anti-inflammatory effect.
Animals
;
Aprotinin/*pharmacology
;
*Cardiopulmonary Bypass
;
Comparative Study
;
Dogs
;
Hemostatics/pharmacology
;
Lung/*blood supply/metabolism/pathology
;
Male
;
Models, Animal
;
Research Support, Non-U.S. Gov't
;
Vascular Resistance/*drug effects
;
Water/metabolism
8.Risk Factor Analysis for Development of Asymptomatic Carotid Stenosis in Koreans.
Yun Jeong LIM ; Young Wook KIM ; Yeon Hyen CHOE ; Chang Seok KI ; Sue Kyung PARK
Journal of Korean Medical Science 2006;21(1):15-19
Many risk factors for atherosclerosis have been proposed to identify high risk individuals. We conducted a retrospective study to determine the risk factors for development of carotid stenosis (CS) in Koreans. Database of 2,805 subjects who underwent a check up of carotid artery for health examination were analyzed. Stenosis (%) of common carotid artery or proximal internal carotid artery was examined with ultrasonography. Subjects were divided into 2 groups (Group I; CS <10%, Group II; CS > or =30%). We compared demographic, laboratory and clinical data between 2 groups to determine the risk factors of CS. One hundred ninety seven subjects (7.0%) were categorized as Group II. At age- and sex-adjusted multivariate analysis, diabetes mellitus, hypertension, cerebrovascular disease, ischemic heart disease, hyperlipidemia, aspirin medication, current smoking, fasting glucose, total cholesterol, low density lipoprotein-cholesterol (LDL-C) and leukocyte count were significant risk factors of CS. At stepwise logistic regression analysis, age, hypertension, hyperlipidemia, LDL-C and leukocyte count were independent risk factors. At subgroup analysis by smoking, age and leukocyte count were independent risk factors in smoker and age and hypertension in nonsmoker.
Adult
;
Age Factors
;
Aged
;
Carotid Stenosis/blood/*epidemiology/etiology
;
Cholesterol/blood
;
Comparative Study
;
Female
;
Humans
;
Korea/epidemiology
;
Lipoproteins, LDL Cholesterol/blood
;
Logistic Models
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Prevalence
;
Retrospective Studies
;
Risk Factors
;
Smoking/adverse effects
9.Threshold of Nuchal Translucency for the Detection of Chromosomal Aberration: Comparison of Different Cut-offs.
Min Hyoung KIM ; Su Hyun PARK ; Hye Jin CHO ; June Seek CHOI ; Joo Oh KIM ; Hyun Kyong AHN ; Joong Sik SHIN ; Jung Yeol HAN ; Moon Young KIM ; Jae Hyug YANG
Journal of Korean Medical Science 2006;21(1):11-14
This study evaluated the sensitivities and false positive rates of the screening test using ultrasonographic measurement of thickness of nuchal translucency (NT) with different cut-offs for chromosomal aberration in a Korean population. We included 2,570 singleton pregnancies undergoing ultrasound between 11 weeks and 14 weeks of gestation in this study. We analyzed the sensitivities of NT alone for screening chromosomal aberration using three cut-offs -2.5 mm, 3.0 mm, and 95th percentile for each crown rump length (CRL). There were 31 chromosomal aberrations (1.2%) including 12 cases of trisomy 21. The numbers of chromosomal aberrations that were detected by NT with different cut-offs of 2.5 mm, 3.0 mm and the 95th percentile CRL were 22, 18 and 23, respectively. At a threshold of 2.5 mm, the sensitivity and the false positive rate for total chromosomal aberrations were 67.7% and 6.3%, respectively. At 3.0 mm, those were 54.8% and 3.5%, respectively. At the 95th percentile CRL, those were 70.9% and 5.8%, respectively. The use of CRL-dependent cut-offs for nuchal translucency improves the detection of chromosomal aberrations when compared to fixed cut-offs in a Korean population.
Adult
;
*Chromosome Aberrations
;
Chromosome Disorders/diagnosis
;
Comparative Study
;
Female
;
Fetal Diseases/*diagnosis/genetics
;
Humans
;
Mass Screening/methods
;
Nuchal Translucency Measurement/*methods
;
Pregnancy
;
Sensitivity & Specificity
10.Transfusion-related Cytomegalovirus Infection Among Very Low Birth Weight Infants in an Endemic Area.
Ai Rhan Ellen KIM ; Yeon Kyung LEE ; Kyung Ah KIM ; Young Kyu CHU ; Byung Yoon BAIK ; Eun Soon KIM ; Sung Cheol YUN ; Ki Soo KIM ; Soo Young PI
Journal of Korean Medical Science 2006;21(1):5-10
This study investigated the incidence of acquired cytomegalovirus (CMV) infection in very low birth weight infants (VLBWI) given CMV seropositive blood, and sought to determine whether filtering and irradiation of blood products could help prevent CMV infection and the time required to clear passively-derived anti-CMV IgG among 80 VLBWI transfused with filtered-irradiated blood, 20 VLBWI transfused with nonfiltered- nonirradiated blood and 26 nontransfused VLBWI. CMV IgG and IgM values were obtained from all blood products prior to transfusions, and from VLBWI at birth until the infants became seronegative. Urine was obtained for CMV culture at birth and every 3-4 weeks until 12 weeks after the final transfusion. The incidence of CMV IgG seropositivity among the 126 infants at birth and the blood products given were 96% and 95%, respectively. The incidence of acquired CMV infection was 4/100 (4%) in the transfused group: 2/80 (2.5%) and 2/20 (10%) in the filtered-irradiated and nonfiltered-nonirradiated transfusion groups, respectively. Approximately 9-10 months elapsed to clear passively acquired CMV IgG. The irradiation and filtering of the blood products did not seem to decrease the transfusion-related CMV infection rate in Korea among VLBWI, however, further validation is recommended in a larger cohort of infants.
Antibodies, Viral/blood
;
Blood Donors
;
Blood Transfusion/*adverse effects/methods
;
Comparative Study
;
Cytomegalovirus/immunology/isolation & purification/radiation effects
;
Cytomegalovirus Infections/blood/prevention & control/*transmission
;
Female
;
Filtration/methods
;
Humans
;
Immunoglobulin G/blood
;
Immunoglobulin M/blood
;
Infant, Newborn
;
Infant, Very Low Birth Weight/*blood
;
Intensive Care Units, Neonatal
;
Linear Models
;
Male
;
Time Factors

Result Analysis
Print
Save
E-mail